Patent · US Active

Cell lines

US10253345B2 · kind B2 · utility

0Cited by
5References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2017
Grant dateApr 9, 2019
Priority date
Expiry dateJun 1, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y601/01
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided inter alia a process for stabilizing a eukaryotic cell line which expresses PylRS and tRNAPyl and which is suitable for incorporation of a gene encoding a target protein containing one or more non-natural amino acids encoded by a nonsense codon which comprises culturing said cell line under conditions in which the adverse effect of tRNAPyl expression on cell viability and/or cell growth is reduced or eliminated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.